Pfizer signs cooperation agreement with SZTE
The University of Szeged (SZTE) announced a cooperation deal with drugmaker Pfizer Gy贸gyszerkereskedelmi Kft., which will result in the university始s patients being able to access the most modern therapies, according to a report by Szeged.hu.
University of Szeged
The announcement notes that the aim of the cooperation is enhancing R&D in the medicine industry, and thus improving the recovery of patients. The cooperation will increase the R&D capacity of SZTE and the number of medicine trials.
SZTE achieved clinical trial center certification under the "Pfizer Inspire" program in October 2018, becoming a part of the company始s special network. Pfizer offers clinical trials to members of this network first, meaning that the number of clinical trials sponsored by Pfizer at the university may grow significantly, says Judit Fendler, SZTE chancellor.
Some 35 successful clinical trials have already been conducted at SZTE, with 11 more to follow, primarily in the fields of oncology, and systematic immflamuation. Thanks to the agreement, patients will have access to the most modern and innovative therapies, well before they become widely accessible.
Pfizer, the largest U.S. drugmaker, had an income of USD 53.6 billion in 2018. The firm has been present in Hungary since 1991, with 80 Pfizer products accessible in Hungary, in 200 different forms. The yearly turnover of its Hungarian subsidiary, Pfizer Gy贸gyszergy谩ri Kft., reached HUF 36 bln in 2017.
ADVERTISEMENT
Farm Input Prices Climb 5.4%聽in Q1-Q3
India's G20 Presidency, Dawn of New Multilateralism - Narend...
AutoWallis Exceeds聽Entire 2022 Revenue, Profit in 9 Months
TikTok Commits to Improved Consumer Communication in Hungary
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.
